Teladoc Health (NYSE:TDOC) Releases FY 2025 Earnings Guidance

Teladoc Health (NYSE:TDOC) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of -1.100–0.500 for the period, compared to the consensus EPS estimate of -1.030. The company issued revenue guidance of $2.5 billion-$2.6 billion, compared to the consensus revenue estimate of $2.5 billion. Teladoc Health also updated its Q1 2025 guidance to -0.400–0.150 EPS.

Analyst Upgrades and Downgrades

Several research analysts recently commented on TDOC shares. Deutsche Bank Aktiengesellschaft raised their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Bank of America raised their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. The Goldman Sachs Group boosted their price target on Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a report on Tuesday, February 18th. Oppenheimer reduced their price objective on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Finally, TD Cowen lowered their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Thirteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $11.81.

Teladoc Health Stock Down 2.5 %

TDOC traded down $0.28 during trading on Wednesday, hitting $10.91. The stock had a trading volume of 10,340,108 shares, compared to its average volume of 8,008,443. The stock has a 50 day simple moving average of $10.58 and a two-hundred day simple moving average of $9.52. The company has a market capitalization of $1.88 billion, a PE ratio of -1.89 and a beta of 1.04. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $15.95.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, research analysts predict that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.95% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.